FDA Creates Biosimilars Overseer In Drug Office; Internal Panel To Advise Application Reviewers
This article was originally published in The Pink Sheet Daily
Executive Summary
Leah Christl brings molecular and cellular biology background to the job of implementing an approval pathway for biosimilars.